Will my GP prescribe Wegovy?

Will My GP Prescribe WeGovy?

WeGovy (semaglutide) is a weight loss medication manufactured by the drugs company Novo Nordisk that has been approved by the National Institute for Health and Care Excellence (NICE) for use in the UK. It is a once-weekly injection pen containing the medication semaglutide, and marketed towards combatting obesity. While WeGovy is available through private medical weight loss clinics, many people wonder if their GP can prescribe WeGovy.

What is WeGovy?

The medication works by mimicking the hormone GLP-1, which is usually created in the intestines after eating a meal, thus reducing appetite and food intake. By mimicking this hormone, WeGovy can help increase feelings of fullness, leading to lower calorie intake and weight loss.

You may have heard of WeGovy as it is the same medication as Ozempic, the injectable pen famed for its game changing weight loss results in celebrities around the world. While Ozempic was originally marketed as a diabetes medication, WeGovy’s sole purpose is the incredible weight loss results it can achieve.

Patients around the UK will have seen the amazing effects of WeGovy, and NICE have now recommended the use of semaglutide in prescribing for patients on the NHS via a GP referral into a specialist weight management service.

Contact Bodyline today to find out more about our safe and effective weight loss programmes and range of treatment options.

"*" indicates required fields

By submitting this form you agree to the Bodyline privacy policy.
This field is for validation purposes and should be left unchanged.

Can I get WeGovy from my GP?

Your GP can refer you to a specialist weight management service where you could be prescribed WeGovy, but only if you meet certain criteria. WeGovy is approved for use by adults with a body mass index (BMI) of 35 or more who have been diagnosed with obesity-related diseases and have not achieved weight loss with other treatments. However, people with a BMI between 30-34.9 with weight-related medical issues could also be prescribed the drug. It has been available to NHS patients in England from Sept 2023 is confirmed by manufacturer Novo Nordisk.  

It’s important to remember that WeGovy is a new medication for the NHS, and there may be waitlists involved or you may not have the required criteria to be referred to the specialist weight management service. If you do not meet the criteria for NHS prescription, WeGovy is still available to you through private and safe medical weight loss clinics like Bodyline, and without the wait.

Patients inject themselves once a week with pens pre-filled with semaglutide. The drug will curb appetite and halt cravings by mimicking the hormone glucagon-like peptide-1 (GLP-1), which is released in the intestines after eating. It leads people to feel fuller and results in people eating less and reducing calorie intake.

Is WeGovy available now?

WeGovy is currently available within medical weight loss treatment programmes with health and wellness clinics like Bodyline. With Bodyline, the process is very simple. Once you’ve gotten in touch with our fantastic customer service team, we can decide which prescription medication is perfect for you and your weight loss goals based on your medical history and measurements.

At Bodyline Clinic, we offer personalised weight loss programs that are designed to help you achieve your weight loss goals in a safe and sustainable way. Our programs include a combination of medical treatments, nutrition advice, and exercise advice to help you lose weight and keep it off for good. If you’re interested in learning more about WeGovy or our weight loss programs, contact Bodyline Clinic today at 0800 995 6036 or fill in our online contact form for a call back. Our team of experts can answer any questions you may have and help you determine which treatment options are right for you.

It’s important to remember that while WeGovy may seem like a quick and easy solution to weight loss, it is not a silver bullet. We should approach it with caution and make sure that it is the right choice for you. Before using any type of weight loss medication, it is important to talk to a qualified medical professional to determine if it’s the right treatment option based on your medical history and personal goals. 

If WeGovy isn’t right for you, we offer a range of medical weight loss treatments in the form of oral pills and injectable therapies, including Phentermine, Saxenda, and more. Get in touch to find out how you can transform your body with the help of Bodyline’s medical weight loss treatments.

Start your medical weight loss journey today

Related blog posts

By now we should all have heard of the incredible weight loss results from GLP-1 receptor agonist medications and their ever-growing popularity. All over the UK, people are searching for access to ‘game changing’ medications to solve their weight problems. Searches for semaglutide, tirzepatide and liraglutide (brand names WeGovy/Ozempic, Mounjaro, and Saxenda respectively) have increased dramatically in the past year, and interest continues to rise. That’s because for the first time ever, there seems to be a potential long-term solution to the obesity epidemic that has afflicted the world over the past 30 years.
If you're on a weight loss journey and are prescribed medication to aid in this process, it's essential to manage your medication intake effectively during Ramadan to ensure both your health and adherence to religious obligations.
Despite the enormous popularity of WeGovy and its incredible impact on weight loss, a shortage of the injectable weight loss therapy has been ongoing in recent months. The semaglutide-containing injection has been dubbed “game-changing” for the treatment of obesity, and demand has been high, but manufacturer Novo Nordisk has struggled to keep up and has only released limited stock.


Contact Bodyline to find out more how we can treat and support you to improve your health and wellbeing.

"*" indicates required fields

Select the Bodyline treatment that you would like to discuss*
By submitting this form you agree to the Bodyline privacy policy.